Case number 1:24-cv-00825
American Regent, Inc. v. Long Grove Pharmaceuticals, LLC > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Aug 19, 2024 | N/A | CASE CLOSED (dlw) (Entered: 08/19/2024) (0) |
| Aug 19, 2024 | 10 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s). (Attachments: # 1 Notice of Voluntary Dismissal)(mdb) (Entered: 08/19/2024) (0) |
| Aug 16, 2024 | 9 | NOTICE of Voluntary Dismissal without Prejudice by American Regent, Inc. as to Long Grove Pharmaceuticals, LLC (Viceconte, Christopher) Modified on 8/19/2024 (dlw). (Entered: 08/16/2024) (2) |
| Aug 15, 2024 | 8 | STIPULATION TO EXTEND TIME for Defendant to respond to Plaintiff's Complaint to August 19, 2024 - filed by Long Grove Pharmaceuticals, LLC. (Metzler, Sara) (Entered: 08/15/2024) (1) |
| Aug 15, 2024 | N/A | SO ORDERED re 8 STIPULATION TO EXTEND TIME for Defendant to answer, move, or otherwise respond to Plaintiff's Complaint to August 19, 2024 (Set/Reset Answer Deadlines: Long Grove Pharmaceuticals, LLC answer due 8/19/2024). ORDERED by Judge Maryellen Noreika on 8/15/2024. (dlw) (Entered: 08/15/2024) (0) |
| Aug 13, 2024 | 7 | SUMMONS Returned Executed by American Regent, Inc..Long Grove Pharmaceuticals, LLC served on 7/25/2024, answer due 8/15/2024. (Viceconte, Christopher) (Entered: 08/13/2024) (2) |
| Jul 24, 2024 | N/A | Case Assigned to Judge Maryellen Noreika. Please include the initials of the Judge (MN) after the case number on all documents filed. Associated Cases: 1:24-cv-00824-MN, 1:24-cv-00825-MN (rjb) (Entered: 07/24/2024) (0) |
| Jul 17, 2024 | 6 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Daiichi Sankyo Company, Limited, Corporate Parent Daiichi Sankyo, Inc., Corporate Parent Daiichi Sankyo U.S. Holdings, Inc for American Regent, Inc. filed by American Regent, Inc.. (Viceconte, Christopher) (Entered: 07/17/2024) (2) |
| Jul 16, 2024 | 1 | COMPLAINT for ANDA/PATENT INFRINGEMENT filed with Jury Demand against Long Grove Pharmaceuticals, LLC (Filing fee $ 405, receipt number ADEDC-4452495.) - filed by American Regent, Inc. (Attachments: # 1 Civil Cover Sheet, # 2 Exhibit 1)(mws) (Entered: 07/17/2024) (0) |
| Jul 16, 2024 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mws) (Entered: 07/17/2024) (3) |
| Jul 16, 2024 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 06/28/2024. Date of Expiration of Patent: 07/01/2041. Thirty Month Stay Deadline: N/A. (mws) Modified on 8/15/2024 (dlw). (Entered: 07/17/2024) (1) |
| Jul 16, 2024 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 11,998,565. (mws) (Entered: 07/17/2024) (1) |
| Jul 16, 2024 | N/A | DEFICIENCY NOTICE issued by the Court to Plaintiff: Pursuant to Fed. R. Civ. P. 7.1 (b)(1), A party must: (1) file the disclosure statement with its first appearance, pleading, petition, motion, response, or other request addressed to the court. Counsel is requested to supplement the docket with an appropriate Rule 7.1 Disclosure Statement. (mws) (Entered: 07/17/2024) (0) |
| Jul 16, 2024 | 5 | Summons Issued as to Long Grove Pharmaceuticals, LLC on 7/16/2024. (mws) (Entered: 07/17/2024) (2) |
